Harte-Hanks Inc (HHS) Drops 7.12% on February 04

Equities Staff  |

Harte-Hanks Inc (HHS) was one of the Russell 2000's biggest losers for Thursday February 04 as the stock slid 7.12% to $3.20, a loss of $-0.245 per share. Starting at an opening price of $3.33 a share, the stock traded between $2.96 and $3.38 over the course of the trading day. Volume was 325,076 shares over 1,772 trades, against an average daily volume of 298,754 shares and a total float of 61.25 million.

The losses send Harte-Hanks Inc down to a market cap of $195.69 million. In the last year, Harte-Hanks Inc has traded between $8.27 and $2.55, and its 50-day SMA is currently $3.27 and 200-day SMA is $4.44.

Harte-Hanks Inc is a multi-channel marketing company. The Company develops integrated solutions that connect brands with prospects and customers, moving them beyond awareness to transactions and brand loyalty.

Harte-Hanks Inc is based out of San Antonio, TX and has some 5,423 employees. Its CEO is Karen A. Puckett / Philip J. Galati.

For a complete fundamental analysis analysis of Harte-Hanks Inc, check out Equities.com’s Stock Valuation Analysis report for HHS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…